Clinical Trials in Brazil / NCT07822230
Recruiting Not applicable

Effects of a Dietary Intervention Based on the Dietary Guidelines for the Brazilian Population on the Reduction of Menopausal Symptoms in Overweight and Obese Women

NCT07822230 · tracked via the Priya Life Science Brazil tracker
Phase
Not applicable
Started
2026-05-06
Last updated
2026-09-29

Condition(s) studied

MenopauseMenopause Hot FlashesOverweight , ObesityPerimenopause, Climacteric SyndromePostmenopauseMenopause-related Hot FlashesMenopause Related ConditionsMenopause SymptomsClimactericum

Investigational drug(s) / intervention(s)

Nutritional guidelines on healthy eating based on the Dietary Guidelines for the Brazilian Population in printed material and 5 in-person and virtual meetingsNutritional guidelines on healthy eating based on the Dietary Guidelines for the Brazilian Population only in printed material

Nutritional guidelines on healthy eating based on the Dietary Guidelines for the Brazilian Population in printed material and 5 in-person and virtual meetings: The intervention group will participate in five monthly Food and Nutrition Education sessions based on the Dietary Guidelines for the Brazilian Population. The first session will be an individual session on nutritional guidance, while the second will be a virtual group session on the NOVA food classification system. The third session will be a virtual group session on nutrition labeling. The fourth session will be a virtual group session on reducing culinary ingredients (salt, sugar, and fat) in food preparation. The fifth session will be an in-person group cooking workshop focused on preparing healthy and practical recipes.

Nutritional guidelines on healthy eating based on the Dietary Guidelines for the Brazilian Population only in printed material: The control group will receive nutritional guidance on healthy eating based on the Dietary Guidelines for the Brazilian Population, provided exclusively as printed material distributed at the start of the study. The guidance will be standardized, with no individual follow-up or in-person meetings.

Study summary

The menopausal transition is associated with significant hormonal changes that negatively impact many women's quality of life. Vasomotor symptoms, sleep disturbances, mood changes, and genitourinary symptoms are frequently reported during this period. Concurrently, there is a tendency toward increased body weight and fat redistribution, specifically central fat accumulation, which raises the risk of metabolic diseases. Although hormonal therapy is effective, it is not suitable for all women, necessitating the consideration of non-pharmacological strategies as therapeutic alternatives. Scientific evidence indicates that healthy dietary patterns and weight loss are associated with reduced menopausal symptom severity.

The objective of the research is to evaluate the effects of a dietary intervention based on the guidelines of the Dietary Guidelines for the Brazilian Population (GAPB) on the reduction of menopausal symptoms.

A randomized clinical trial will be conducted to assess whether improving dietary quality and reducing body weight contribute to alleviating menopausal symptoms. Participants will be assigned to two groups: a control group (CG) and an intervention group (IG). Both groups will receive nutritional guidance based on the GAPB; however, the CG will receive the guidelines in printed format, whereas the IG will receive them through group sessions. The study will include perimenopausal or postmenopausal women who are overweight or obese and experiencing menopausal symptoms. Validated instruments will be administered at the beginning and end of the study to assess dietary patterns, menopausal symptoms, and nutritional status.

Eligibility

Sex
FEMALE
Min age
40 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Aged 40 to 65 years * In the perimenopausal or postmenopausal stage (based on clinical criteria and/or self-report) * Exhibiting clinical symptoms characteristic of menopause * Diagnosed as overweight or obese (BMI ≥ 25 kg/m²) * Internet access via mobile phone or computer * Agreeing to participate by signing the Informed Consent Form (ICF) Exclusion Criteria: * Pregnancy * Undergoing hormone replacement therapy * Taking medications for obesity * Diagnosed with active neoplasms undergoing chemotherapy or immunosuppressive treatment * Cognitive impairment

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Irmandade da Santa Casa de Misericórdia de Porto Alegre Porto Alegre Rio Grande do Sul Recruiting

More Federal University of Health Science of Porto Alegre trials in Brazil

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07822230 on ClinicalTrials.gov ↗ ← All trials in Brazil